blood clotting from at least two different COVID-19 vaccines.On Tuesday, Canada reported its first case of a rare blood clot in a person who had received the AstraZeneca COVID-19 vaccine.
Canada reports 1st blood clot in AstraZeneca COVID-19 vaccine recipient Meanwhile, the U.S. federal health agencies recommended an immediate “pause” in the use of Johnson & Johnson’s single-dose COVID-19 vaccine after six U.S.
recipients developed a rare type of blood clotting, called cerebral venous sinus thrombosis (CVST).This comes after the European Medicines Agency ruled last week that it found a “possible link” between the AstraZeneca coronavirus vaccine and a rare blood clotting disorder after several dozen cases that came mainly from Europe and.